LGALS3 and Huntington disease: Suppressing Gal3 by genetic and pharmacological approaches reveal that up-regulated Gal3 levels in microglia contributes to HD pathogenesis in a feed-forward NFκB-dependent and NLRP-3 inflammasome-dependent manner.